The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. The Green Templeton Lectures 2009 explored the theme 'Addicted to Big Pharma? Reconciling business,...
Published 06/09/09
This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment.
Published 06/04/09